Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids

被引:46
作者
He, Liyu [1 ]
Peng, Youming [1 ]
Liu, Hong [1 ]
Liu, Yinghong [1 ]
Yuan, Shuguang [1 ]
Liu, Fuyou [1 ]
Yang, Danyi [1 ]
Liu, Huanhuan [1 ]
Chen, Xian [1 ]
Shao, Jing [1 ]
Fu, Min [1 ]
机构
[1] Cent S Univ, Dept Nephrol, Xiangya Hosp 2, Key Lab Kidney Dis & Blood Purificat Hunan, Changsha 410011, Hunan, Peoples R China
关键词
Corticosteroid; Efficacy; Idiopathic membranous nephropathy; Intravenous cyclophosphamide; Low-dose tacrolimus; Nephrotic syndrome; METHYLPREDNISOLONE PLUS CHLORAMBUCIL; DEPENDENT NEPHROTIC SYNDROME; RANDOMIZED CONTROLLED-TRIAL; 10-YEAR FOLLOW-UP; LIVER-REGENERATION; STEROID-RESISTANT; CYCLOSPORINE-A; MYCOPHENOLATE-MOFETIL; COMBINED THERAPY; CYCLOPHOSPHAMIDE;
D O I
10.5301/jn.5000199
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Evidence regarding the optimal dose of tacrolimus (TAC) in treatment of idiopathic membranous nephropathy (IMN) remains inconclusive. The objective of this study was to evaluate the efficacy and safety of low-dose TAC combined with prednisone for patients with IMN. Methods: We conducted a randomized prospective cohort study in IMN patients: 28 patients received oral TAC (target whole blood concentration of 2-4 ng/mL) plus prednisone for 12 months, and 28 patients received prednisone combined with intravenous cyclophosphamide (CYC) (750 mg/m(2) body surface) once every 4 weeks for 24 weeks. Results: Of the 56 patients who completed the 12-month treatment, complete remission (CR) occurred in 8 (28.6%) of the CYC group and 18 (64.3%) of the TAC group; partial remission (PR) occurred in 10 (35.7%) of the CYC group and 7 (25.0%) of the TAC group. The probability of remission (either CR or PR) was higher in the TAC group than in the CYC group (p = 0.0439, by log-rank test). Furthermore, a significantly greater improvement in proteinuria and serum albumin levels was observed in the TAC group compared with the CYC group. Patients treated with TAC can often show a rapid increase in their serum albumin levels before any obvious reduction of urinary protein excretion. Side effects were mild and transitory in both groups. Conclusion: The results demonstrated that the combined therapy of low-dose TAG and prednisone is an effective and safe therapeutic method for Chinese adults with IMN. Low-dose TAG accompanied by prednisone is enough to induce remission in the majority of patients with IMN.
引用
收藏
页码:564 / 571
页数:8
相关论文
共 44 条
[1]  
Ambalavanan S, 1996, J AM SOC NEPHROL, V7, P290
[2]   Treatment of idiopathic membranous nephropathy with the combination of steroids, tacrolimus and mycophenolate mofetil:: results of a pilot study [J].
Ballarin, Jose ;
Poveda, Rafael ;
Ara, Jordi ;
Perez, Laurea ;
Calero, Francesca ;
Grinyo, Josep M. ;
Romero, Ramon .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (11) :3196-3201
[3]   Mycophenolate mofetil in idiopathic membranous nephropathy: A clinical trial with comparison to a historic control group treated with cyclophosphamide [J].
Branten, Amanda J. ;
du Buf-Vereijken, Peggy W. ;
Vervloet, Marc ;
Wetzels, Jack F. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (02) :248-256
[4]   Management of membranous nephropathy: When and what for treatment [J].
Cattran, D .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (05) :1188-1194
[5]   Membranous nephropathy: Quo vadis? [J].
Cattran, DC .
KIDNEY INTERNATIONAL, 2002, 61 (01) :349-350
[6]   Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial [J].
Cattran, DC ;
Appel, GB ;
Hebert, LA ;
Hunsicker, LG ;
Pohl, MA ;
Hoy, WE ;
Maxwell, DR ;
Kunis, CL .
KIDNEY INTERNATIONAL, 2001, 59 (04) :1484-1490
[7]   One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus [J].
Chamienia, A ;
Biedunkiewicz, B ;
Król, E ;
Debska-Slizien, A ;
Rutkowski, B .
TRANSPLANTATION PROCEEDINGS, 2006, 38 (01) :81-85
[8]   Tacrolimus Combined With Corticosteroids in Treatment of Nephrotic Idiopathic Membranous Nephropathy: A Multicenter Randomized Controlled Trial [J].
Chen, Min ;
Li, Hang ;
Li, Xia-Yu ;
Lu, Fu-Ming ;
Ni, Zhao-Hui ;
Xu, Fei-Fei ;
Li, Xue-Wang ;
Chen, Jiang-Hua ;
Wang, Hai-Yan .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (03) :233-238
[9]   Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate [J].
du Buf-Vereijken, PWG ;
Branten, AJW ;
Wetzels, JFM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (05) :1142-1148
[10]   Emerging strategies to preserve renal function [J].
Francois, Helene ;
Jacquet, Antoine ;
Beaudreuil, Severine ;
Seidowsky, Alexandre ;
Hebibi, Hadia ;
Charpentier, Bernard ;
Durrbach, Antoine .
JOURNAL OF NEPHROLOGY, 2011, 24 (02) :133-141